Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Narrative (Details)

v3.22.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2022
Jun. 30, 2021
Revenue Recognition      
Proceeds from Laboratory Services Reimbursed by Medicare     $ 0.5
Contract with Customer, Liability, Total $ 25.1 $ 25.1 $ 20.0
Contract with Customer, Liability, Revenue Recognized $ 1.9 $ 15.2